|
Maternal
Screening
All pregnant
women are now being offered maternal serum screening (also known as AFP
testing, triple or quad screening) for certain birth defects. It
is important that you understand this screening process so you can decide
whether or not to be tested. We encourage you to talk with your health
care provider about this process.
What
is the purpose of this screening?
Your
unborn baby makes some proteins which can be detected in your blood during
pregnancy. Measuring certain proteins at 15 to 20 weeks from the
first day of the last menstral period can help identify whether you may
be at increased risk to have a baby with a neural tube defect (spina bifida),
Down syndrome, or trisomy 18.
What
is neural tube defect?
A neural
tube defect occurs very early in pregnancy when the cells that become the
skull, brain, and spinal column fail to form a closed tube. Neural
tube defects occur in about one in 1,000 births. Often couples who
have a baby with a neural tube defect have no family history of these problems.
If this
tube does not form correctly at the top, the brain and skull will not develop.
This is called anencephaly. Babies with anencephaly do not survive.
If there
is an opening along the lower portion of the tube, the spine does not close
completely. This is called spina bifida. Size and location
of the opening determine how severe the spina bifida is. Complications
may include problems with walking and bowel and bladder control.
What
is Down Syndrome?
In each
of our cells, we have 46 chromosomes (23 pairs). They give instructions
for our development. Down syndrome results when there is an extra
number 21 chromosome (three, instead of a pair).
Any woman
at any age can have a baby with Down syndrome, although the risk increases
with the age of the mother. Babies with Down syndrome usually have
a mild to moderate degree of mental retardation, as well as other physical
problems.
What
is trisomy 18?
Trisomy
18 results when there is an extra number 18 chromosome. Babies with
trisomy 18 have more severe birth defects and mental retardation.
How does
maternal serum screening work?
This
screening measures the levels of up to three different proteins from the
unborn baby or placenta that circulate in your blood:
-
Alpha-fetoprotein
(AFP)
-
Unconjugated
estriol (uE3)
-
Human chorionic
gonadotropin (hCG)
- Inhibin
The levels
of these proteins depend on how far along you are in your pregnancy.
Elevated
levels of AFP may mean that the unborn baby has a neural tube defect.
Low levels
of all three proteins may mean the unborn baby has trisomy 18.
In pregnancies
where the unborn baby is affected with Down syndrome, there may be a special
pattern in the levels of all three proteins:
-
AFP and uE3
are low
-
hCG and inhibin are elevated
Using the
levels of these four proteins in your blood, along with your age, we can
calculate a more accurate estimate that an unborn baby might be affected
with one of these problems.
What
does it mean if my screen is negative?
About
95 out of 100 women screened will have a negative result. If the
Down syndrome risk is found to be less than 1 in 365 (equal to a 35-year-old
woman's risk) and the AFP level is not elevated, then the result is reported
as screen negative.
Unfortunately,
a negative screen does not guarantee the baby will be normal, because maternal
serum screening does not identify all unborn babies with these problems.
It leads to the detection of:
-
6 out of
10 unborn babies with Down syndrome
-
8 out of
10 unborn babies with spina bifida
-
9 out of
10 unborn babies with anencephaly
-
8 out of
10 unborn babies with trisomy 18
Since it
is only useful for Down syndrome, trisomy 18, spina bifida, and anencephaly,
maternal serum screening will not pick up other birth defects a baby may
have.
What
does it mean if my screen is positive?
In 5
out of 10 of every 100 pregnant women tested, the result is "screen positive."
This result does not necessarily mean the baby has a problem—it means that
the unborn baby is at increased risk for a problem.
-
At the University
of Washington Medical Center, a screen positive means:
-
The risk
of that the unborn baby has Down syndrome is greater than or equal to 1
in 365 (a 35-year-old woman's risk to have a baby with Down syndrome),
OR
-
The AFP is
more than 2.5 times the normal value, OR
-
The risk
that the unborn baby has trisomy 18 is increased because all three proteins
are low (approximately half the normal values) OR
-
Simply that
the woman may be 35 or older
If your result
is screen positive, you may find it very helpful to talk with your health
care provider or a genetic counselor, who can help explain the results
and discuss further testing. To find out if there is a problem, other
tests such as ultrasound, repeat blood tests, or amniocentesis may be offered.
In many cases an ultrasound is the only other test needed to find the cause
of the positive screen. (For example, having twins may be the reason
the test was positive.)
Whether
or not you have more testing is up to you. You will need to decide
if the risk seems high enough to consider diagnostic tests such as ultrasound
or amniocentesis.
Remember,
The maternal serum screening test is not a diagnostic test. It will
not tell you whether or not your unborn baby has or doesn't have a problem.
It will simply indicate the chance that the baby has a problem.
Keep in
mind that the vast majority of women with "screen positive" results do
not have babies with Down syndrome, trisomy 18, or a neural tube defect.
Who
might decide NOT to have screening?
Knowing
about these problems ahead of time may change the management of your pregnancy
and delivery. However, some couples have decided that they would
not consider having an amniocentesis for any reason and/or just do not
want to know during the pregnancy if their baby has one of these problems. If that is the case, you should not have your blood drawn.
How
confident can I be that the results are accurate?
The University
of Washington Medical Center employs experienced registered medical technologists
to perform these tests.
Our laboratory
participates in voluntary quarterly proficiency surveys sponsored by the
College of American Pathologists and has a strict quality control program
to assure reliable results.
Lab personnel
meet frequently with health care providers and genetic counselors to ensure
clear communication about laboratory testing and clinical interpretation
of test results.
Top of Page
|